511 Therapeutics, Inc.

New Filing

CIK: 0001946264·Biotechnology·DELAWARE·Filed: Oct 6, 2022

Total Offering

$599,998

Amount Sold

$49,999

Investors

1

First Sale

Sep 23, 2022

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2022
Non-Accredited Investors: No

Related Persons

Name	Role
Shuguang Zhang	Related Person
Yancen Lu	Related Person
Uwe B. Sleytr	Related Person

Company

511 Therapeutics, Inc.

1770 MASSACHUSETTS AVENUE

CAMBRIDGE, MA, 02140

(617) 818-7126

SEC Filing

0001946264-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.